The metabolic profile in active acromegaly is gender-specific

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 1, 2013, Pages

  Ciresi, A ^a,b   Amato, M C ^a   Pivonello, R ^b   Nazzari, E ^c   Grasso, L F ^b   Minuto, F ^c   Ferone, D ^c   Colao, A ^a,b   Giordano, Carla ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACROMEGALY; ADULT; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MULTICENTER STUDY; OBESITY; PANCREAS ISLET BETA CELL; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ACROMEGALY; ADULT; AGED; BLOOD GLUCOSE; COHORT STUDIES; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; METABOLOME; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 84872073482     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2896     Document Type: Article

References (50)

1. Frantz AG, Rabkin MT 1965 Effects of estrogen and sex difference on secretion of human growth hormone. J Clin Endocrinol Metab 25:1470-1480
2. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51-58
3. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosén T, Lindstedt G, Lundberg PA, Bengtsson BA 1994 Serum insulin-like growth factor 1 in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 41:351-357
4. Colao A, Amato G, Pedroncelli AM, Baldelli R, Grottoli S, Gasco V, Petretta M, Carella C, Pagani G, Tambura G, Lombardi G 2002 Gender- and age-related differences in the endocrine parameters of acromegaly. J Endocrinol Invest 25:532-538
5. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA 1997 Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82:550-555
6. Johansson AG 1999 Gender difference in growth hormone response in adults. J Endocrinol Invest 22(5 Suppl):58-60
7. Tanaka S, Fukuda I, Hizuka N, Takano K 2010 Gender differences in serum GH and IGF-I levels and the GH response to dynamic tests in patients with acromegaly. Endocr J 57:477-483
8. Edén Engström B, Burman P, Karlsson FA 2002 Men with acromegaly need higher doses of octreotide than women. Clin Endocrinol (Oxf) 56:73-77
9. Colao A, Pivonello R, Cappabianca P, Briganti F, Tortora F, Auriemma RS, De Martino MC, Marzullo P, Lombardi G 2005 Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly. Clin Endocrinol (Oxf) 63:342-349
10. Arafat AM, Möhlig M, Weickert MO, Perschel FH, Purschwitz J, Spranger J, Strasburger CJ, Schöfl C, Pfeiffer AF 2008 Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab 93:1254-1262
11. Petersenn S, Buchfelder M, Gerbert B, Franz H, Quabbe HJ, Schulte HM, Grussendorf M, Reincke M; Participants of the German Acromegaly Register 2009 Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register. Clin Endocrinol (Oxf) 71:400-405
12. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S; Acromegaly Consensus Group 2010 A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141-3148
13. Tucker GT, Casey C, Phillips PJ, Connor H, Ward JD, Woods HF 1981 Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol 12:235-246
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
15. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force 2007 American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 13(Suppl 1):1-68
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin in man. Diabetologia 28:412-419
17. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470
18. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Renn W, Gerich J 2000 Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295-301
19. Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, Boyko EJ, Leonetti DL, McNeely MJ, Fujimoto WY, Kahn SE 2009 Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 32:335-341
20. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A; For the AlkaMeSy Study Group 2010 Visceral adiposity index (VAI): a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33:920- 922
21. Giordano C, Ciresi A, Amato MC, Pivonello R, Auriemma RS, Grasso LF, Galluzzo A, Colao A 25 November 2011 Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study. Pituitary doi: 10.1007/s11102-011-0365-5
22. Ciresi A, Amato MC, Pizzolanti G, Giordano Galluzzo C 2012 Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. J Clin Endocrinol Metab 97:2907-2915
23. van den Berg G, Veldhuis JD, Frölich M, Roelfsema F 1996 An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 81:2460-2467
24. Jaffe CA, Ocampo-Lim B, Guo W, Krueger K, Sugahara I, DeMott-Friberg R, Bermann M, Barkan AL 1998 Regulatory mechanisms of growth hormone secretion are sexually dimorphic. J Clin Invest 102:153-164
25. Zadik Z, Chalew SA, McCarter Jr RJ, Meistas M, Kowarski AA 1985 The influence of age on the 24 hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 60:513-516
26. Gatford KL, Egan AR, Clarke IJ, Owens PC 1998 Sexual dimorphism of the somatotrophic axis. J Endocrinol 157:373-389
27. Freda PU, Landman RE, Sundeen RE, Post KD 2001 Gender and age in the biochemical assessment of cure of acromegaly. Pituitary 4:163-171
28. Turner HE, Adams CB, Wass JA 1999 Pituitary tumours in the elderly: a 20 year experience. Eur J Endocrinol 140:383-389
29. van der Lely AJ, Harris AG, Lamberts SW 1992 The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex. Clin Endocrinol (Oxf) 37:181-185
30. Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F 1996 New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol 134:352-356
31. Esbjörnsson M, Rundqvist HC, Mascher H, Österlund T, Rooyackers O, Blomstrand E, Jansson E 2012 Sprint exercise enhances skeletal muscle p70S6k phosphorylation and more so in women than in men. Acta Physiol (Oxf) 205:411-422
32. Sucunza N, Barahona MJ, Resmini E, Fernández-Real JM, Farrerons J, Lluch P, Puig T, Wägner AM, Ricart W, Webb SM 2008 Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females. Eur J Endocrinol 159:773-779
33. Kvist H, Chowdhury B, Grangård U, Tylén U, Sjöström L 1988 Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 48:1351-1361
34. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX 1997 Visceral fat and race-dependent health risks in obese non-diabetic premenopausal women. Diabetes 46:456-462
35. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriège P, Després JP 1999 Gender difference in postprandial lipemia: importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 19:2448-2455
36. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, Heine RJ, Nijpels G, Seidell JC; Hoorn study 2004 Trunk fat and leg fat have independent and opposite associations with fasting and post load glucose levels: the Hoorn study. Diabetes Care 27:372-377
37. Ding QF, Hayashi T, Zhang XJ, Funami J, Ge L, Li J, Huang XL, Cao L, Zhang J, Akihisa I 2007 Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women. J Diabetes Complications 21:315-319
38. Royer M, Castelo-Branco C, Blümel JE, Chedraui PA, Danckers L, Bencosme A, Navarro D, Vallejo S, Espinoza MT, Gómez G, Izaguirre H, Ayala F, Martino M, Ojeda E, Onatra W, Saavedra J, Tserotas K, Pozzo E, Manriquez V, Prada M, Grandia E, Zuniga C, Lange D, Sayegh F; Collaborative Group for Research of the Climacteric in Latin America 2007 The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric 10:164-170
39. Whitcroft S, Herriot A 2011 Insulin resistance and management of the menopause: a clinical hypothesis in practice. Menopause Int 17:24-28
40. Gohlke-Barwolf C 2000 Coronary artery disease-is menopause a risk factor? Basic Res Cardiol 95(Suppl 1):I77-I83
41. Spencer CP, Godsland IF, Stevenson JC 1997 Is there a menopausal metabolic syndrome? Gynecol Endocrinol 11:341-355
42. Carr MC 2003 The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88:2404-2411
43. Mercuro G, Zoncu S, Dragoni F 2003 Gender differences in cardiovascular risk factors. Ital Heart J 4:363-366
44. Sites CK, Toth MJ, Cushman M, L'Hommedieu GD, Tchernof A, Tracy RP, Poehlman ET 2002 Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 77:128-135
45. Gaspard U 2009 Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women. Maturitas 62:362-365
46. Wajchenberg BL 2000 Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738
47. Ritchie SA, Connell JM 2007 The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17:319-326
48. Blagosklonny MV 2010 Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle 9:683-688
49. Blagosklonny MV 2012 Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to. Aging 4:350-358
50. Miquet JG, Giani JF, Martinez CS, Muñoz MC, González L, Sotelo AI, Boparai RK, Masternak MM, Bartke A, Dominici FP, Turyn D 2011 Prolonged exposure to GH impairs insulin signaling in the heart. J Mol Endocrinol 47:167-177